About
Solutions
Pipeline
Publications
News
Careers
Contact Us
en
Open main menu
News
Loading...
CN
Track Our News on
All
Press Release
Media Coverage
All
2024-04-29
2024-04-15
2024-04-02
2024-03-20
2024-03-12
2024-02-27
2024-02-06
2024-01-31
2024-01-22
2024-01-19
2023-11-24
2023-11-24
Previous
2 / 6
Next
Previous
2 / 6
Next
MindRank Named as One of the Top 10 Emerging AI Tech Companies by Forbes China
MindRank Honored in Global Health & Pharma Magazine's 2024 Biotechnology Awards Winners
MindRank and BioMetas Announce Strategic Partnership to Establish One-Stop Service Platform for AI+ Drug Research and Development
J. Cheminform. | Automated molecular structure segmentation from documents using ChemSAM
ChemRxiv | A Smart Strategy for Photoresponsive Molecules: Utilizing Generative Pre-trained Transformer and TDDFT Calculations in Drug Delivery
MindRank Recognized in HolonIQ 2023 East Asia Health Tech 200
MindRank Achieves Milestone in Merck China Knowledge Graph Project, Advancing New Drug R&D with Enhanced Intelligence Insights from AI Large Models
Bioorganic Chemistry | Discovery of 2,4-diarylaminopyrimidine derivatives bearing sulfonamide moiety as novel FAK inhibitors
MindRank Founder Zhangming Niu Named in 2023 Forbes China Outstanding Foreign Talent Selection Honoree List
MindRank and Henlius (2696.HK) Announce Strategic Collaboration for AI-Driven Development of Next-Gen Antibody Drug Conjugates (ADCs) and Anti-Aging Therapy Platform
News - MindRank
Galen Growth | MindRank Features in the HealthTech 250 most promising early-stage Digital Health ventures list for 2023
MindRank Founder Zhangming Niu Awarded Forbes China 100 Outstanding Overseas Returnees
